Stocktoria

SANUWAVE Health, Inc. SNWV

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
6/9
Piotroski F — financial health
-19.06
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials (annual, from 10-K)

FYRevenueNet incomeGross profitFree cash flowEquity
2025$44.1M$11.8M$34.0M$1.9M$1.6M
2024$32.6M-$33.1M$24.6M$2.0M-$15.8M
2023$19.3M-$25.8M$14.4M-$4.5M-$44.5M
2022$16.7M-$10.3M$12.4M-$41.0M
2021$13.0M-$27.3M$8.0M-$6.9M-$39.0M
2020$3.6M-$30.9M$2.9M-$12.8M-$13.7M

Recent insider activity (Form 4)

InsiderRoleDateActionSharesPrice
Opaleye Management Inc.10% owner2026-05-01Sell10,081$16.11
Opaleye Management Inc.10% owner2026-05-01Sell500$16.11
Opaleye Management Inc.10% owner2026-04-30Sell1,000$16.15
Opaleye Management Inc.10% owner2026-04-30Sell24,000$16.15
Opaleye Management Inc.10% owner2026-04-29Sell23,360$17.25
Opaleye Management Inc.10% owner2026-04-29Sell1,000$17.25
Opaleye Management Inc.10% owner2026-04-28Sell2,500$18.47
Opaleye Management Inc.10% owner2026-04-28Sell43,788$18.47

Why these scores methodology →

Piotroski F-score: 6/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -19.06 (distress)

  • Working capital / assets 0.182
  • Retained earnings / assets -6.499
  • EBIT / assets 0.132
  • Equity / liabilities 0.045

Source: SEC EDGAR filings · CIK 0001417663 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.